The decision to label the scFvD2B with 99mTc was based on the fact that it has a slower tumor uptake (3 h) than PSMA peptides [33] and is therefore not a good candidate for labeling with a very short half-life radionuclide such as 68Ga. This evidence concerns the gene FOLH1 and neoplasm.